13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC
SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2023-09-30, filed 2023-11-13, with 80 holding rows worth $329,815,812.
- Accession
- 0001420506-23-001985
- Filer
- CIK 1816307
- Filed
- 2023-11-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2023
A holdings report, 80 entries on the cover page, a total value of $329,815,812 stated on the cover page (in dollars after the unit check, H1), rows summing to $329,815,812 with VALUE read as dollars as filed, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerSILVERARC CAPITAL, LLC 028-20993
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| SPDR SER TR | 78464A870 | S&P BIOTECH | 300,000 | $21,906,000 | dollars as filed | call |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 1,307,435 | $20,748,993 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 590,829 | $13,535,892 | dollars as filed | |
| MERUS N V | N5749R100 | COM | 500,000 | $11,790,000 | dollars as filed | |
| SOLENO THERAPEUTICS INC | 834203309 | COM | 370,000 | $10,918,700 | dollars as filed | |
| INTRA-CELLULAR THERAPIES INC | 46116X101 | COMMON STOCK | 208,730 | $10,872,746 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 200,000 | $10,116,000 | dollars as filed | call |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 590,000 | $8,796,900 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 200,000 | $8,712,000 | dollars as filed | |
| POSEIDA THERAPEUTICS INC | 73730P108 | COM | 3,567,985 | $8,491,804 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 71,531 | $8,297,596 | dollars as filed | |
| BIOGEN INC COM | 09062X103 | Stock | 28,069 | $7,214,014 | dollars as filed | |
| UROGEN PHARMA LTD | M96088105 | COMMON STOCK | 508,883 | $7,129,451 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 31,424 | $7,097,739 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W108 | COM | 4,117,920 | $7,041,643 | dollars as filed | |
| ORIC PHARMACEUTICALS INC | 68622P109 | COM | 1,123,345 | $6,796,237 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 220,000 | $6,542,800 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 150,000 | $6,534,000 | dollars as filed | call |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 651,372 | $6,350,877 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 5,000,000 | $6,350,000 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 260,537 | $5,972,811 | dollars as filed | |
| MACROGENICS INC | 556099109 | COM | 1,264,158 | $5,890,976 | dollars as filed | |
| BIOCRYST PHARMACEUTICALS INC COM | 09058V103 | Stock | 791,671 | $5,605,031 | dollars as filed | |
| NOVO-NORDISK A S ADR | 670100205 | ADR | 60,000 | $5,456,400 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 106,600 | $5,391,828 | dollars as filed | put |
| VERACYTE INC COM | 92337F107 | Stock | 239,571 | $5,349,620 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 530,400 | $5,107,752 | dollars as filed | call |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 6,130,268 | $5,105,287 | dollars as filed | |
| OLEMA PHARMACEUTICALS INC | 68062P106 | COM | 407,801 | $5,036,342 | dollars as filed | |
| HUMANA INC COM | 444859102 | Stock | 10,000 | $4,865,200 | dollars as filed | |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 13,765 | $4,786,641 | dollars as filed | |
| Gilead Sciences,Inc. | 375558103 | COM | 62,789 | $4,705,408 | dollars as filed | |
| PLIANT THERAPEUTICS INC | 729139105 | COM | 250,409 | $4,342,092 | dollars as filed | |
| CARIBOU BIOSCIENCES INC COM | 142038108 | Stock | 892,786 | $4,267,517 | dollars as filed | |
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 250,000 | $3,967,500 | dollars as filed | call |
| TELA BIO INC | 872381108 | COM | 490,471 | $3,923,768 | dollars as filed | |
| INSMED INC COM PAR $.01 | 457669307 | Stock | 150,387 | $3,797,272 | dollars as filed | |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 110,114 | $3,479,602 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 200,000 | $2,982,000 | dollars as filed | call |
| Reviva Pharmaceuticals Holdings Inc | 76152G100 | Common Stock | 564,000 | $2,752,320 | dollars as filed | put |
| ZURA BIO LTD | G9TY5A101 | COMMON STOCK | 404,040 | $2,666,664 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 500,000 | $2,515,000 | dollars as filed | |
| MOLECULAR TEMPLATES INC | 608550208 | COM | 354,608 | $2,241,123 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 228,934 | $2,204,634 | dollars as filed | |
| TREVI THERAPEUTICS INC COM | 89532M101 | Stock | 927,415 | $2,021,765 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 1,114,461 | $2,006,030 | dollars as filed | |
| CERUS CORP | 157085101 | COM | 1,203,890 | $1,950,302 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 53,996 | $1,844,503 | dollars as filed | |
| EVOGENE LTD | M4119S104 | SHS | 3,100,000 | $1,818,150 | dollars as filed | |
| INTELLIA THERAPEUTICS INC | 45826J105 | COM | 53,018 | $1,676,429 | dollars as filed | |
| AKERO THERAPEUTICS INC | 00973Y108 | COM | 31,336 | $1,584,975 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 199,000 | $1,363,150 | dollars as filed | call |
| AEROVATE THERAPEUTICS INC | 008064107 | COM | 100,000 | $1,357,000 | dollars as filed | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 26,629 | $1,284,849 | dollars as filed | |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 100,000 | $1,168,000 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 41,455 | $1,161,155 | dollars as filed | |
| SAREPTA THERAPEUTICS INC | 803607100 | COM | 9,197 | $1,114,860 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 801,600 | $1,018,032 | dollars as filed | call |
| ANNEXON INC | 03589W102 | COM | 399,716 | $943,330 | dollars as filed | |
| 89BIO INC | 282559103 | COM | 60,247 | $930,214 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 10,000 | $884,800 | dollars as filed | |
| SAGIMET BIOSCIENCES INC A | 786700104 | COMMON STOCK | 100,000 | $880,000 | dollars as filed | |
| SCHRODINGER INC COM | 80810D103 | Stock | 30,311 | $856,892 | dollars as filed | |
| VOYAGER THERAPEUTICS INC | 92915B106 | COMMON STOCK | 103,966 | $805,737 | dollars as filed | |
| KARYOPHARM THERAPEUTICS INC | 48576U106 | COM | 561,955 | $753,020 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 47,438 | $727,699 | dollars as filed | |
| POINT BIOPHARMA GLOBAL INC | 730541109 | COM | 93,700 | $624,979 | dollars as filed | |
| REZOLUTE INC | 76200L309 | COMMON STOCK | 433,240 | $571,877 | dollars as filed | |
| ALIGOS THERAPEUTICS INC COM NEW | 01626L105 | Stock | 631,887 | $472,020 | dollars as filed | |
| COMPUGEN LTD | M25722105 | ORD | 350,188 | $325,675 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 121,110 | $318,519 | dollars as filed | |
| RELMADA THERAPEUTICS INC | 75955J402 | COMMON STOCK | 100,000 | $300,000 | dollars as filed | |
| SYNDAX PHARMACEUTICALS INC | 87164F105 | COM | 20,000 | $290,400 | dollars as filed | |
| ELOXX PHARMACEUTICALS INC NEW | 29014R202 | Com | 54,075 | $260,101 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 10,000 | $260,100 | dollars as filed | |
| CLENE INC | 185634102 | COM | 500,000 | $247,950 | dollars as filed | |
| ACELYRIN INC | 00445A100 | COM | 23,000 | $233,910 | dollars as filed | put |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 9,711 | $68,948 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 104,828 | $17,821 | dollars as filed | |
| ACLARIS THERAPEUTICS INC COM | 00461U105 | Stock | 2,400 | $16,440 | dollars as filed | put |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-23-001985 | this filing | 2023-11-13 | acceptance time not in the bulk data set |